Form 4: Sight Sciences Director Brenda Larsen-Becker Receives $130,000 Equity Grant

Brenda Jane Larsen-Becker, a Director at Sight Sciences, Inc., was granted 30,952 Restricted Stock Units valued at approximately $130,000 as part of the company's Non-Employee Director Compensation Program.

Summary

• Brenda Jane Larsen-Becker, a Director of Sight Sciences, Inc. (SGHT), acquired 30,952 Restricted Stock Units (RSUs) on June 5, 2025.
• The RSUs were granted at a price of $0, reflecting a non-cash equity compensation award.
• The value of the RSU grant is approximately $130,000, determined by the closing price of Sight Sciences' common stock on the grant date.
• Each RSU represents a contingent right to receive one share of the Issuer's common stock.
• The RSUs are scheduled to vest on the earlier of June 5, 2026, or the date of the Issuer's 2026 annual meeting of stockholders.
• Vesting is contingent upon Ms. Larsen-Becker's continued service as a director on the Company's board through the vesting date.
• Following this transaction, Ms. Larsen-Becker beneficially owns 79,040 securities, which include 48,088 shares of Common Stock and the newly acquired 30,952 unvested RSUs.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it reflects a standard and beneficial corporate governance practice of aligning director interests with shareholders through equity compensation. It is a routine filing and does not indicate any extraordinary positive or negative events for the company's operations or financial health.

Positives

• The grant of Restricted Stock Units to a director aligns the director's financial interests with those of the shareholders, promoting long-term value creation.
• This equity compensation is a standard practice for non-employee directors, indicating a structured and competitive compensation program.

Future Outlook

The future outlook for the reporting person's equity holdings includes the vesting of the 30,952 RSUs on the earlier of June 5, 2026, or the date of the Issuer's 2026 annual meeting of stockholders, subject to continued service.

Management Comments

• The grant reflects a component of the Issuer's Non-Employee Director Compensation Program.

Industry Context

The compensation of non-employee directors with equity, such as Restricted Stock Units, is a common and widely accepted practice across various industries for publicly traded companies. This method is used to align the interests of the board members with the long-term performance of the company and its shareholders.

Comparison to Industry Standards

• The grant of RSUs as part of a non-employee director compensation program is consistent with standard corporate governance practices observed in comparable companies within the medical device and ophthalmology sectors.
• Many companies, such as Alcon Inc. (ALC) or Bausch + Lomb Corporation (BLCO), utilize similar equity-based incentives for their independent directors to foster long-term commitment and performance alignment.

Corporate Governance

Related Party Transactions

• The grant of 30,952 Restricted Stock Units to Brenda Jane Larsen-Becker, a director of Sight Sciences, Inc., constitutes a related party transaction as it involves compensation to a member of the company's board of directors. This is a standard and disclosed form of compensation.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's incentives with shareholder interests, potentially leading to better long-term decision-making and value creation.
• Employees: No direct impact on employees is indicated by this specific filing.

Next Steps

• The 30,952 RSUs granted to Brenda Jane Larsen-Becker are expected to vest on the earlier of June 5, 2026, or the date of Sight Sciences' 2026 annual meeting of stockholders, subject to her continued service.

Key Dates

Recommendation

Keywords

Sight Sciences, SGHT, Form 4, SEC filing, Restricted Stock Units, RSUs, equity compensation, director compensation, insider transaction, beneficial ownership